1 September 2022

Biologics Spondyloarthritis

Triple therapy: the patients’ perspective

18 August 2022

Biologics

ACR releases new vaccination guidelines

21 July 2022

Biologics Rheumatoid Arthritis

Metformin hope for knee OA

14 July 2022

Biologics COVID-19 PBS

Covid antiviral access expanded

23 June 2022

Biologics Gout PBAC

‘Game-changer’ on horizon for alopecia areata

2 June 2022

Ankylosing Spondylitis Biologics

Biologics improve psoriasis but not CV risk

28 April 2022

Biologics Pain

Kicking the opioid-first prescribing habit

28 April 2022

Biologics PBS

Regulatory review – March 2022 PBAC recommendations

21 April 2022

Biologics Diet Exercise Juvenile Arthritis Osteoporosis TGA

NSAIDs blunt clodronate effect on preventing fractures

21 April 2022

Biologics COVID-19 Global Health

Covid-19 Global Rheumatology Alliance registry set to close

7 April 2022

Biologics COVID-19

Bad news for the usual suspects

17 March 2022

Ankylosing Spondylitis Biologics Pharmacy Guild of Australia

Mavrilimumab opens up GCA promise

17 March 2022

Biologics COVID-19 Reactive Arthritis

A silver lining to sulfasalazine’s covid fear

3 March 2022

Anti JAKS Biologics COVID-19 Fibromyalgia

Antipyretics ‘reduce covid immunity, help fight TB’

3 March 2022

Biologics COVID-19

Rheumatology patients share their experiences of the covid pandemic

24 February 2022

Ankylosing Spondylitis Biologics Polymyalgia Rheumatica Rheumatoid Arthritis Spondyloarthritis

Why men won’t take allopurinol